From: Self-reported disability in women with fibromyalgia from a tertiary care center
 | Mild (n = 13) | Moderate (n = 54) | Severe (n = 47) | Total (n = 114) | P value | Size effect |
---|---|---|---|---|---|---|
Age in years | 48.2 ± 5.9 | 49.9 ± 7.2 | 46.8 ± 6.4 | 48.4 ± 6.8 | 0.07 | 0.02a |
Years of education | 10 ± 3.5 | 10.2 ± 3.6 | 10.1 ± 3.2 | 10.1 ± 3.4 | 0.98 | 0.01a |
Time since onset of pain (months) | 48 (24) | 48 (64) | 36 (42) | 48 (60) | 0.22 | 0.02b |
Time since FM diagnosis (months) | 36 (46) | 34 (36) | 12 (36) | 24 (42) | 0.08 | 0.03b |
Body mass index | 29.1 ± 4.5 | 28.4 ± 3.1 | 28.9 ± 3.7 | 28.7 ± 3.5 | 0.72 | 0.01a |
Pain Intensity | 5.0 ± 2.3 | 6.2 ± 2.1 | 7.3 ± 1.6 | 6.5 ± 2.1 | < 0.001 | 0.12a |
Number of drugs | 2.3 ± 1.1 | 2.12 ± 1.2 | 2.08 ± 1.2 | 2.1 ± 1.2 | 0.85 | 0.01a |
Pharmacological treatment | 11 [84.6] | 49 [90.7] | 39 [82.9] | 99 [86.8] | 0.49 | – |
 Celecoxib | 5 [38.4] | 21 [38.8] | 9 [19.1] | 35 [30.7] | 0.08 |  |
 Nonsteroidal anti-inflammatory drugs | 3 [23.0] | 9 [16.6] | 13 [27.6] | 25 [21.9] | 0.41 |  |
 Pregabalin or Gabapentin | 6 [46.1] | 30 [55.5] | 24 [51.0] | 60 [52.6] | 0.79 |  |
 Antidepressants | 9 [69.2] | 27 [50.0] | 29 [61.7] | 65 [57.0] | 0.31 |  |
 Tramadol-acetaminophen | 5 [38.4] | 19 [35.1] | 13 [27.6] | 37 [32.4] | 0.64 |  |
 Benzodiazepines | 0 [0] | 7 [12.9] | 4 [8.5] | 11 [9.6] | 0.34 |  |
 Quetiapine | 0 [o] | 0 [o] | 2 [4.2] | 2 [1.7] | 0.23 |  |
Medication adherence | ||||||
 Non-pharmacological treatment | 2 [15.3] | 5 [9.2] | 8 [17.0] | 15 [13.0] | 0.35 |  |
 Adherent | 5 [38.4] | 26 [48.1] | 17 [36.1] | 48 [42.1] |  |  |
 Non-adherent | 2 [15–3] | 19 [35.1] | 17 [36.1] | 38 [33.0] |  |  |
 Unknown | 4 [30.7] | 4 [7.4] | 5 [10.6] | 13 [11.3] |  |  |